Progression of diabetic nephropathy and vitamin D serum levels: A pooled analysis of 7722 patients

IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Endocrinology, Diabetes and Metabolism Pub Date : 2023-09-24 DOI:10.1002/edm2.453
Yomna E. Dean, Sameh Samir Elawady, Wangpan Shi, Ahmed A. Salem, Arinnan Chotwatanapong, Haya Ashraf, Tharun Reddi, Prashant Obed Reddy Dundi, Waleed Yasser Habash, Mohamed Yasser Habash, Safaa Ahmed, Hana M. Samir, Ahmed Elsayed, Aryan Arora, Abhinav Arora, Abdelrahman Elsayed, Tamer Mady, Yousef Tanas, Yusef Hazimeh, Mohamed Alazmy, Hani Aiash
{"title":"Progression of diabetic nephropathy and vitamin D serum levels: A pooled analysis of 7722 patients","authors":"Yomna E. Dean,&nbsp;Sameh Samir Elawady,&nbsp;Wangpan Shi,&nbsp;Ahmed A. Salem,&nbsp;Arinnan Chotwatanapong,&nbsp;Haya Ashraf,&nbsp;Tharun Reddi,&nbsp;Prashant Obed Reddy Dundi,&nbsp;Waleed Yasser Habash,&nbsp;Mohamed Yasser Habash,&nbsp;Safaa Ahmed,&nbsp;Hana M. Samir,&nbsp;Ahmed Elsayed,&nbsp;Aryan Arora,&nbsp;Abhinav Arora,&nbsp;Abdelrahman Elsayed,&nbsp;Tamer Mady,&nbsp;Yousef Tanas,&nbsp;Yusef Hazimeh,&nbsp;Mohamed Alazmy,&nbsp;Hani Aiash","doi":"10.1002/edm2.453","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background and Aim</h3>\n \n <p>Low serum Vitamin D levels have been associated with diabetic nephropathy (DN). Our study aimed to analyse the serum levels of vitamin D in patients suffering from DN and the subsequent changes in serum vitamin D levels as the disease progresses.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>PubMed, Embase, SCOPUS and Web of Science were searched using keywords such as ‘25 hydroxyvitamin D’ and ‘diabetic nephropathy’. We included observational studies that reported the association between the serum 25 hydroxy vitamin D levels and diabetic nephropathy without restriction to age, gender, and location. R Version 4.1.2 was used to perform the meta-analysis. The continuous outcomes were represented as mean difference (MD) and standard deviation (SD) and dichotomous outcomes as risk ratios (RR) with their 95% confidence interval (CI).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Twenty-three studies were included in our analysis with 7722 patients. Our analysis revealed that vitamin D was significantly lower in diabetic patients with nephropathy than those without nephropathy (MD: −4.32, 95% CI: 7.91–0.74, <i>p</i>-value = .0228). On comparing diabetic patients suffering from normoalbuminuria, microalbuminuria, or macroalbuminuria, we found a significant difference in serum vitamin D levels across different groups. Normoalbuminuria versus microalbuminuria showed a MD of −1.69 (95% CI: −2.28 to −1.10, <i>p</i>-value = .0002), while microalbuminuria versus macroalbuminuria showed a MD of (3.75, 95% CI: 1.43–6.06, <i>p</i>-value = .0058), proving that serum vitamin D levels keep declining as the disease progresses. Notwithstanding, we detected an insignificant association between Grade 4 and Grade 5 DN (MD: 2.29, 95% CI: −2.69–7.28, <i>p</i>-value = .1862).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Serum Vitamin D levels are lower among DN patients and keep declining as the disease progresses, suggesting its potential benefit as a prognostic marker. However, on reaching the macroalbuminuria stage (Grades 4 and 5), vitamin D is no longer a discriminating factor.</p>\n </section>\n </div>","PeriodicalId":36522,"journal":{"name":"Endocrinology, Diabetes and Metabolism","volume":"6 6","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2023-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638614/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrinology, Diabetes and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/edm2.453","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Aim

Low serum Vitamin D levels have been associated with diabetic nephropathy (DN). Our study aimed to analyse the serum levels of vitamin D in patients suffering from DN and the subsequent changes in serum vitamin D levels as the disease progresses.

Methods

PubMed, Embase, SCOPUS and Web of Science were searched using keywords such as ‘25 hydroxyvitamin D’ and ‘diabetic nephropathy’. We included observational studies that reported the association between the serum 25 hydroxy vitamin D levels and diabetic nephropathy without restriction to age, gender, and location. R Version 4.1.2 was used to perform the meta-analysis. The continuous outcomes were represented as mean difference (MD) and standard deviation (SD) and dichotomous outcomes as risk ratios (RR) with their 95% confidence interval (CI).

Results

Twenty-three studies were included in our analysis with 7722 patients. Our analysis revealed that vitamin D was significantly lower in diabetic patients with nephropathy than those without nephropathy (MD: −4.32, 95% CI: 7.91–0.74, p-value = .0228). On comparing diabetic patients suffering from normoalbuminuria, microalbuminuria, or macroalbuminuria, we found a significant difference in serum vitamin D levels across different groups. Normoalbuminuria versus microalbuminuria showed a MD of −1.69 (95% CI: −2.28 to −1.10, p-value = .0002), while microalbuminuria versus macroalbuminuria showed a MD of (3.75, 95% CI: 1.43–6.06, p-value = .0058), proving that serum vitamin D levels keep declining as the disease progresses. Notwithstanding, we detected an insignificant association between Grade 4 and Grade 5 DN (MD: 2.29, 95% CI: −2.69–7.28, p-value = .1862).

Conclusion

Serum Vitamin D levels are lower among DN patients and keep declining as the disease progresses, suggesting its potential benefit as a prognostic marker. However, on reaching the macroalbuminuria stage (Grades 4 and 5), vitamin D is no longer a discriminating factor.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
糖尿病肾病进展与维生素D血清水平:7722例患者的汇总分析
背景与目的低血清维生素D水平与糖尿病肾病(DN)有关。我们的研究旨在分析DN患者的血清维生素D水平以及随着疾病进展血清维生素D水平的变化。方法以“25羟基维生素D”、“糖尿病肾病”等关键词检索PubMed、Embase、SCOPUS和Web of Science。我们纳入了报道血清25羟基维生素D水平与糖尿病肾病之间关联的观察性研究,不受年龄、性别和位置的限制。采用R Version 4.1.2进行meta分析。连续结局用均差(MD)和标准差(SD)表示,二分类结局用风险比(RR)表示,其95%可信区间(CI)。结果23项研究纳入我们的分析,共7722例患者。我们的分析显示,糖尿病肾病患者的维生素D明显低于无肾病患者(MD: - 4.32, 95% CI: 7.91-0.74, p值= 0.0228)。在比较正常白蛋白尿、微量白蛋白尿和大量白蛋白尿的糖尿病患者时,我们发现不同组的血清维生素D水平有显著差异。正常白蛋白尿与微量白蛋白尿的MD为- 1.69 (95% CI: - 2.28 ~ - 1.10, p值= 0.0002),而微量白蛋白尿与大量白蛋白尿的MD为(3.75,95% CI: 1.43 ~ 6.06, p值= 0.0058),证明血清维生素D水平随着疾病进展而持续下降。尽管如此,我们发现4级和5级DN之间存在不显著的关联(MD: 2.29, 95% CI:−2.69-7.28,p值= .1862)。结论血清维生素D水平在DN患者中较低,且随着病情进展持续下降,提示其作为预后指标的潜在价值。然而,在达到大量蛋白尿阶段(4级和5级)时,维生素D不再是一个判别因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Endocrinology, Diabetes and Metabolism
Endocrinology, Diabetes and Metabolism Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
5.00
自引率
0.00%
发文量
66
审稿时长
6 weeks
期刊最新文献
Trends in Alzheimer's-Related Mortality Among Type 2 Diabetes Patients in the United States: 1999–2019 Association Between TyG-BMI Index and Hyperuricemia in Adult Women Issue Information The Role of Serum Free Fatty Acids in Endothelium-Dependent Microvascular Function Association of Albumin-To-Creatinine Ratio With Diabetic Retinopathy Among US Adults (NHANES 2009–2016)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1